News | May 13, 2025
Morepen Board proposed dividend after 23 years
Scores highest PAT of Rs. 118 crore in FY25
Scores highest PAT of Rs. 118 crore in FY25
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
Investment demonstrates confidence in America’s commitment to science and innovation
Distribution agreement enables FUJIFILM India to offer Spectra Logic advanced tape libraries and software solutions to enterprise customers and channel partners
Bayer expects 2025 to be the most difficult year of its turnaround
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
A new weapon in the global fight against malaria
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Subscribe To Our Newsletter & Stay Updated
